Individual Treatment of COVID-19 by Application of Alpha-1-antitrypsin
Individual Treatment of COVID-19 by Application of Alpha-1-antitrypsin
The blood concentrations of alpha-1-antitrypsin are monitored during COVID-19. The clinical course of patients that received AAT infusion for clinical indication is monitored.
The blood concentrations of alpha-1-antitrypsin are monitored during COVID-19. The clinical course of patients that received AAT infusion for clinical indication is monitored. Clinical outcomes, blood inflammatory markers, and virus load are monitored.
Inclusion Criteria:
Exclusion Criteria: